TOP HEADLINES
• Joharis' arrest to lead to bigger exposures
• MSEB threatens to cancel PPA with DPC
• MERC asks MSEB to justify clearing DPC
• McDonald's apologies in French fries issue
• Power tariff to go up in Delhi from June 1
• A-I MD suspended to ensure fair probe: Govt
• Asia's first 'Green Park' to come up in AP
• 'Mascrenhas supended due to A-I power play'
• US tech spending cut by up to 50%
- - More

CORPORATE HEADLINES
• Colour-Chem FY-01 net down by 57.55%
• TV 18 MD purchases 7,000 shares
• Operations halted at Jindal Strips' Vizag Unit
• PSI Data Systems clarifies on news item
• A+ rating to Excel Industries' NCD issue
• LIC Housing Finance FY-01 results on May 31
• BSE imposes special margin on 3 Scrips
- - More

MARKET REPORT
Market@May 24: Day's report
Software stocks decline during the second half of the day. Zee manages to gain more than 4 per cent. Tata Power, Bhel and BSES gain smartly.

DAILY TECHNICALS
Trading strategy for May 25, 2001
Sensex, Wipro, Sterlite Optical, Tisco, Gujarat Ambuja... Check out what you can do on Friday.

FUND FILE
Franklin India Balanced Fund
The fund has adopted a conservative strategy of a less volatile debt portfolio but it would be too early to take a stance on its performance given its brief track record.

Prudential ICICI Growth Fund
Prudential ICICI Growth has delivered a reasonable 24.35 per cent to beat its benchmark index on the back of a diversified yet tech-heavy portfolio.

STOCK TALK
'Market may be vulnerable to a few more shocks'
'We could become a tech superpower in 10 years if our government does a good job,' says Ramesh Shrichand Damani.

SPECIAL REPORT
'How we built Infosys from scratch'
The lessons they learnt along the way are applicable throughout the world, Infosys chairman
N R Narayana Murthy told Wharton School management graduates.

MARKET IMPACT
'MSCI downgrade won't affect market much'
VSNL: Status quo and waiting to go

REPORTS
He promises invincible security
Vijay Takanti's firm is leveraging the fact that the e-signature Act has been cleared by Congress and trying to provide technology that is not available.

Dr Reddy's sees robust drug pipeline
Dr Reddy's Laboratories expects two of its anti-diabetes drugs to enter phase III clinical trials in the last quarter of 2001.

COLUMN
Cracks already in the JPC's gameplan
'Excluding UTI, which has been at the centre of all the controversy connected with the stock market crisis, suggested an outrageous cover up and made a monkey of those who had been baying for an investigation into its activities,' says Sucheta Dalal.

SPECIAL
IT industry woes: layoffs, ban on foreign jaunts, cost-cuts...
Faced with a slowdown, a now-subdued infotech industry is tightening its belt and reining in expenses.

Firms go back on job offers, students panic
Many firms have withdrawn job offers made to students at campus interviews.

THE BUDGET & GOVT POLICIES
The Rediff Budget Special: Full coverage
Rail Budget 2001-2002: Full coverage
Credit Policy 2001-2002: Full coverage
Exim Policy 2001-2002: Full coverage
Economic Survey 2000-2001: Full coverage